Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 30%
Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy copycats, with rare exceptions.
Hers
since
auto-detected in 279 stories
7 days ago
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 40%
The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy copycats, with rare exceptions.
Novo Nordisk opens weight loss drug Wegovy to telehealth; Hims & Hers shares rocket 40%
The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy copycats, with rare exceptions.
12 days ago
FDA sounds alarm over drug taken by millions that changes people's GENITALS due to horrific side effect
These hair aid products, which are in spray and serum formats, are not approved by the FDA but they are available via a number of telehealth companies including Hims, Hers, and Ro.
34 days ago
Hims & Hers shares rise as company adds new weight-loss medications to platform
Hims & Hers is adding Zepbound, Mounjaro, and the generic injection liraglutide to its platform.
48 days ago
Stocks making the biggest moves midday: Tesla, Palantir, Nvidia, Hims & Hers and more
These are the stocks posting the largest moves in midday trading.
69 days ago
Hims & Hers shares plunge 28% on concerns over weight loss business, margins
Hims & Hers on Monday released fourth-quarter results that disappointed on gross margin and sparked concerns about the future of its weight loss business.
70 days ago
Hims & Hers shares plunge 28% on concerns over weight loss business, margins
Hims & Hers on Monday released fourth-quarter results that disappointed on gross margin and sparked concerns about the future of its weight loss business.
Hims & Hers shares tumble after company misses on margin, says may stop selling some weight loss drugs
Hims & Hers Health reported fourth-quarter results on Monday that beat analysts' expectations, but the stock sank in extended trading.
72 days ago
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
|← first ← previous page 2 of 3 next → last →|